The findings mark one of the longest progression-free survival outcomes ever reported in advanced lung cancer
First-in-human study of investigational SOS1 inhibitor shows encouraging safety profile and early anti-tumor activity in patients with metastatic solid tumors
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
AAV vectors are widely used in gene therapy for their strong therapeutic potential
The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich
Transition to a fermentation-based globally integrated CDMO platform
This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access
BMS is moving beyond conversational AI into what it describes as “agentic” systems
The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample
We are building an AI-native operating system for pharma sales and distribution
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
